联合王国从2026年开始启动45M英镑AI驱动的抗药性感染防治项目。 UK launches £45M AI-driven project to combat drug-resistant infections, starting in 2026.

联合王国发起了一项4 500万英镑的AI-动力倡议,由Fleming倡议和GSK牵头,以对抗抗药性感染,包括强健的Gram-阴性细菌和像Aspergillus这样的致命真菌。 The UK has launched a £45 million AI-powered initiative, led by the Fleming Initiative and GSK, to fight drug-resistant infections, including tough Gram-negative bacteria and deadly fungi like Aspergillus. 伦敦帝国学院的研究人员使用人工智能和超级计算法,目的是加速抗生素的发现,预测疾病爆发,改进治疗。 Using AI and supercomputing, researchers at Imperial College London aim to accelerate antibiotic discovery, predict outbreaks, and improve treatments. 该项目始于2026年,包括六个研究方案,侧重于新的药物设计、免疫反应、处方和全球监测,在世界各地分享研究结果,以加强全球抗微生物抗药性。 The project, beginning in 2026, includes six research programs focused on new drug design, immune responses, prescribing, and global surveillance, with findings shared worldwide to strengthen global defenses against antimicrobial resistance.